60mg 3ml tirzepatide Flex-Dose 3 mL Injectable 10 mg/mL I have a vial that

Drugs in this class In the UK, the following incretin mimetics are available for type 2 diabetic patients (trade name first, generic name in brackets): Bydureon (Exenatide) taken once weekly Byetta (Exenatide) taken twice daily Lyxumia (lixisenatide) taken once daily Trulicity (Dulaglutide) taken once weekly Victoza (Liraglutide) taken once daily Ozempic (Semaglutide) take once a week Byetta and Bydureon are the same medical drug

By engaging glucagon-like peptide-1 (GLP-1), glucagon (GCG), and glucose-dependent insulinotropic polypeptide (GIP) receptors simultaneously, the drug may modulate blood glucose levels and energy balance

Employers are largely accepting the use of GLP-1s for diabetes and weight loss

The most commonly reported side effect is mild injection site irritation in the early weeks, which typically resolves

You can read the full article at The worldwide obesity epidemic is accompanied by a higher incidence of cardiovascular disease (CVD), specifically stroke and heart attacks

But if a patient taking these drugs experiences vision loss, they should call their internist about possibly adjusting the dosage or stopping the medication